The Taiwan Precision Medicine Initiative: A Cohort for Large-Scale Studies
Abstract
The Taiwan Precision Medicine Initiative (TPMI), a project initiated by the Academia Sinica in collaboration with 16 major medical centers around Taiwan, has recruited 565,390 participants who consented to provide DNA samples for genetic profiling and grant access to their electronic medical records (EMR) for studies to develop precision medicine. Access to the EMR is both retrospective and prospective, allowing researchers to conduct prospective studies over time. Genetic profiling is done with population-optimized SNP arrays for the Han Chinese populations that enable genetic analyses such as genome-wide association, phenome-wide association, and polygenic risk score studies to evaluate common disease risk and pharmacogenetic response. Furthermore, the TPMI participants agree to be contacted for future research opportunities related to their genetic risks and receive personalized genetic risk profiles with health management recommendations. TPMI has established the TPMI Data Access Platform (TDAP), a central database and analysis platform that both safeguards the security of the data and facilitates academic research. The TPMI is the largest non-European cohort that merges genetic profiles with EMR in the world. With a cohort that can be followed over time, it can be utilized to validate genetic risk prediction models, conduct clinical trials to show the efficacy of risk-based health management, and optimize health policies based on genetic risks. In this report, we describe the TPMI study design, the population and genetic characteristics of the TPMI cohort, and the power it provides to conduct crucial studies in developing precision medicine on a population and personal level. As Han Chinese represent almost 20% of the world’s population, the results of TPMI studies will benefit >1.4 billion people around the world and serve as a model for developing population-based precision medicine.
Competing Interest Statement
The authors have declared no competing interest.
Subject Area
- Biochemistry (13371)
- Bioengineering (10182)
- Bioinformatics (32560)
- Biophysics (16756)
- Cancer Biology (13849)
- Cell Biology (19670)
- Clinical Trials (138)
- Developmental Biology (10626)
- Ecology (15729)
- Epidemiology (2067)
- Evolutionary Biology (20037)
- Genetics (13231)
- Genomics (18362)
- Immunology (13470)
- Microbiology (31528)
- Molecular Biology (13148)
- Neuroscience (68675)
- Paleontology (509)
- Pathology (2129)
- Pharmacology and Toxicology (3675)
- Physiology (5735)
- Plant Biology (11784)
- Synthetic Biology (3307)
- Systems Biology (8038)
- Zoology (1814)